Are trajectories of depressive symptoms during the first half of drug-sensitive pulmonary tuberculosis treatment associated with loss to follow-up? A secondary analysis of longitudinal data.
Paulo Ruiz-GrossoChristian Loret de MolaLarissa OteroCesar Ugarte-GilPublished in: BMJ open (2023)
The findings suggest that a trajectory of increasing DSs during the first half of PTB treatment is associated with a higher risk of LTFU during the second half.